HIF-1 activity is constitutively active in many aggressive cancers, and is typically elevated in hypoxic tumor regions (80, 81); since HIF-1 promotes transcription of the gene coding for the transferrin receptor, it would be expected to increase the intracellular iron pool (82–85). This evidence concerns the gene TFRC and cancer.